There’s a New Lens in Town: Avaira™ Arrives

By Tom Nicholson, Director of Corporate Accounts, CooperVision Inc.

CooperVision launched its newest lens, Avaira™, in June. We believe it's the best daily-wear, two-week replacement lens available. There are many clinical benefits of the lens. It has a high water content of greater than 45 percent, which provides hydrogel-like comfort, and it has a low modulus of less than 0.50 MPa, which results in fewer mechanical or physiological complications such as superior epithelial arcuate lesions and contact lens-induced papillary conjunctivitis.

AQUAFORM™, CooperVision's patented material technology, surrounds the siloxane chains giving the material hydrophilic properties. AQUAFORM creates charged areas within the material that form hydrogen bonds with the water molecules, locking the water into the lens material.

With this naturally wettable material, Avaira retains water, minimizing dehydration and increasing comfort and deposit resistance. In addition, the highly wettable material aids resistance to lipid and protein deposits.

The aspheric front-surface optics result in sharper, crisper visual acuity, and the UV blocker in the lens aids protection in outdoor environments. The Avaira lens can be positioned so it complements the CooperVision premium material product portfolio. For example, the Biomedics® XC lens is positioned as an entry-level, two-week aspheric lens made with PC Technology™. The 100-Dk Avaira is a premium two-week aspheric silicone hydrogel lens that is naturally wettable. And the Biofinity® is the premium monthly aspheric silicone hydrogel lens with naturally wettable characteristics.

In this initial launch, Avaira is available in minus powers to -6.00D. Higher minus and plus powers will follow later this year or early next.

Find out more about CooperVision's newest contact lens advancements by visiting coopervision.com, or by contacting me directly at tnicholson@CooperVision.com or 317.417.0677.